{"transactions":[{"id":878855,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":64382,"kind":"person","name":"Kway Jasmine","position":1,"cik":"0001808135","reported_name":"Kway Jasmine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO - Singapore Volition"}}],"security":"Common Stock","published_at":"2026-02-27T21:30:58.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":173000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On February 26, 2026, the reporting person was awarded 173,000 restricted stock units (\"RSUs\") under the Issuer's 2024 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs will be earned in twelve approximately equal monthly installments commencing on March 1, 2026. Once earned, they will remain subject to additional time-based vesting in a single installment on February 26, 2027, and are generally subject to continued service by the reporting person throughout each applicable earning and vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have been earned and vested as of the vesting date."}],"balance_after":418614,"source":{"system":"sec-edgar","filing":"0001477932-26-001097","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793226001097/form4.xml","form_type":"4"}},{"id":932890,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":64382,"kind":"person","name":"Kway Jasmine","position":1,"cik":"0001808135","reported_name":"Kway Jasmine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO - Singapore Volition"}}],"security":"Common Stock","published_at":"2026-01-23T21:05:22.000Z","date":"2026-01-22","kind":"grant","planned":false,"acquired":true,"shares":42000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On March 17, 2025, the reporting person was awarded 140,000 restricted stock units (\"RSUs\") under the Issuer's 2024 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to June 30, 2025 and December 31, 2025 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 42,000 RSUs vesting. The RSUs are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 14,000 units on each of March 17, 2026, 2027 and 2028, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. The rights with respect to the remaining 98,000 RSUs did not vest and were cancelled on June 30, 2025 and January 22, 2026, respectively."}],"balance_after":245614,"source":{"system":"sec-edgar","filing":"0001477932-26-000358","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793226000358/form4.xml","form_type":"4"}},{"id":1063239,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":64382,"kind":"person","name":"Kway Jasmine","position":1,"cik":"0001808135","reported_name":"Kway Jasmine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO - Singapore Volition"}}],"security":"Common Stock","published_at":"2025-08-19T20:05:16.000Z","date":"2025-08-15","kind":"grant","planned":false,"acquired":true,"shares":12507,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On August 15, 2025, the reporting person was awarded 12,507 restricted stock units (\"RSUs\") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs will be earned in six approximately equal monthly installments commencing on September 1, 2025. Once earned, they will remain subject to additional time-based vesting in two installments of 6,254 units and 6,253 units on each of November 1, 2025 and February 1, 2026, respectively, and are generally subject to continued service by the reporting person throughout each applicable earning and vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have been earned and vested as of the applicable vesting date."}],"balance_after":203614,"source":{"system":"sec-edgar","filing":"0001477932-25-006095","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225006095/form4.xml","form_type":"4"}},{"id":1126744,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":64382,"kind":"person","name":"Kway Jasmine","position":1,"cik":"0001808135","reported_name":"Kway Jasmine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO - Singapore Volition"}}],"security":"Common Stock","published_at":"2025-06-03T20:07:04.000Z","date":"2025-06-01","kind":"grant","planned":false,"acquired":true,"shares":8327,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 1, 2025, the reporting person was awarded 8,327 restricted stock units (\"RSUs\") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs partially vest in three installments of 2,776 units, 2,776 units, and 2,775 units on each of June 1, 2025, July 1, 2025 and August 1, 2025, respectively, are also subject to further time-based vesting in a single installment on August 1, 2025, and are generally subject to continued service throughout each applicable vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested."}],"balance_after":191107,"source":{"system":"sec-edgar","filing":"0001477932-25-004375","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225004375/form4.xml","form_type":"4"}},{"id":1233966,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":64382,"kind":"person","name":"Kway Jasmine","position":1,"cik":"0001808135","reported_name":"Kway Jasmine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO - Singapore Volition"}}],"security":"Common Stock","published_at":"2025-03-04T21:02:14.000Z","date":"2025-03-01","kind":"grant","planned":false,"acquired":true,"shares":16708,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On March 1, 2025, the reporting person was awarded 16,708 restricted stock units (\"RSUs\") under the Issuer's 2024 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs partially vest in three installments of 5,570 units, 5,569 units, and 5,569 units on each of March 1, 2025, April 1, 2025 and May 1, 2025, respectively, are also subject to further time-based vesting in a single installment on March 1, 2026, and are generally subject to continued service throughout each applicable vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested."}],"balance_after":182780,"source":{"system":"sec-edgar","filing":"0001477932-25-001461","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225001461/form4.xml","form_type":"4"}},{"id":1290364,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":64382,"kind":"person","name":"Kway Jasmine","position":1,"cik":"0001808135","reported_name":"Kway Jasmine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO -Singapore Volition"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-31T21:05:45.000Z","date":"2025-01-29","kind":"grant","planned":false,"acquired":true,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction involved an amendment of outstanding options, resulting in the deemed cancellation of the \"old\" options and the grant of \"replacement\" options. The \"old\" options were originally granted on February 11, 2019, vested in full and were exercisable at 12 months from the date of grant, and were exercisable for five years from the date first exercisable. The \"replacement\" options are fully-vested and expire on February 11, 2029 (ten years from the original date of grant)."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported transaction involved an amendment of outstanding options, resulting in the deemed cancellation of the \"old\" options and the grant of \"replacement\" options. The \"old\" options were originally granted on February 11, 2019, vested in full and were exercisable at 12 months from the date of grant, and were exercisable for five years from the date first exercisable. The \"replacement\" options are fully-vested and expire on February 11, 2029 (ten years from the original date of grant)."}],"balance_after":50000,"derivative":{"exercise_price":3.25,"exercise_date":"2020-02-11","expiration_date":"2029-02-11","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001477932-25-000612","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225000612/form4.xml","form_type":"4"}},{"id":1290363,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":64382,"kind":"person","name":"Kway Jasmine","position":1,"cik":"0001808135","reported_name":"Kway Jasmine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO -Singapore Volition"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-31T21:05:45.000Z","date":"2025-01-29","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction involved an amendment of outstanding options, resulting in the deemed cancellation of the \"old\" options and the grant of \"replacement\" options. The \"old\" options were originally granted on February 11, 2019, vested in full and were exercisable at 12 months from the date of grant, and were exercisable for five years from the date first exercisable. The \"replacement\" options are fully-vested and expire on February 11, 2029 (ten years from the original date of grant)."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported transaction involved an amendment of outstanding options, resulting in the deemed cancellation of the \"old\" options and the grant of \"replacement\" options. The \"old\" options were originally granted on February 11, 2019, vested in full and were exercisable at 12 months from the date of grant, and were exercisable for five years from the date first exercisable. The \"replacement\" options are fully-vested and expire on February 11, 2029 (ten years from the original date of grant)."}],"balance_after":0,"derivative":{"exercise_price":3.25,"exercise_date":"2020-02-11","expiration_date":"2025-02-11","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001477932-25-000612","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793225000612/form4.xml","form_type":"4"}},{"id":1346418,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":64382,"kind":"person","name":"Kway Jasmine","position":1,"cik":"0001808135","reported_name":"Kway Jasmine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Singapore Volition"}}],"security":"Common Stock","published_at":"2024-12-03T21:01:36.000Z","date":"2024-12-01","kind":"grant","planned":false,"acquired":true,"shares":15169,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On December 1, 2024, the reporting person was awarded 15,169 restricted stock units (\"RSUs\") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs partially vest in three installments of 5,057 units, 5,056 units, and 5,056 units on each of December 1, 2024, January 1, 2025 and February 1, 2025, respectively, are also subject to further time-based vesting in a single installment on July 1, 2025, and are generally subject to continued service throughout each applicable vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested."}],"balance_after":166072,"source":{"system":"sec-edgar","filing":"0001477932-24-007805","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793224007805/form4.xml","form_type":"4"}},{"id":1417087,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":64382,"kind":"person","name":"Kway Jasmine","position":1,"cik":"0001808135","reported_name":"Kway Jasmine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO - Singapore Volition"}}],"security":"Common Stock","published_at":"2024-09-04T20:04:50.000Z","date":"2024-09-01","kind":"grant","planned":false,"acquired":true,"shares":15668,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On September 1,2024, the reporting person was awarded 15,668 restricted stock units (\"RSUs\") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs partially vest in three installments of 5,223 units, 5,223 units, and 5,222 units on each of September 1, 2024, October 1, 2024 and November 1, 2024, respectively, are also subject to further time-based vesting in a single installment on June 1, 2025, and are generally subject to continued service throughout each applicable vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested."}],"balance_after":150903,"source":{"system":"sec-edgar","filing":"0001477932-24-005507","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793224005507/form4.xml","form_type":"4"}},{"id":1432059,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":64382,"kind":"person","name":"Kway Jasmine","position":1,"cik":"0001808135","reported_name":"Kway Jasmine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Singapore Volition"}}],"security":"Common Stock","published_at":"2024-08-16T20:06:06.000Z","date":"2024-08-15","kind":"grant","planned":false,"acquired":true,"shares":16750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On Sept 28, 2023, the reporting person was awarded 67,000 restricted stock units (\"RSUs\") under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to Dec 31, 2023 and June 30, 2024 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 16,750 RSUs vesting. The RSUs are further subject to a 3-year time-based vesting schedule, vesting in three installments of 5,583 units, 5,583 units, and 5,584 units on each of Sept 28, 2024, 2025 and 2026, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. As reported in Jan 2024, the rights with respect to 28,475 RSUs subject to the award previously vested and remain subject to time-based vesting. The rights with respect to the remaining 21,775 RSUs did not vest and were cancelled on August 15, 2024."}],"balance_after":135235,"source":{"system":"sec-edgar","filing":"0001477932-24-005028","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793224005028/form4.xml","form_type":"4"}},{"id":1494257,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":64382,"kind":"person","name":"Kway Jasmine","position":1,"cik":"0001808135","reported_name":"Kway Jasmine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO - Singapore Volition"}}],"security":"Common Stock","published_at":"2024-06-04T20:05:56.000Z","date":"2024-06-01","kind":"grant","planned":false,"acquired":true,"shares":13570,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 1, 2024, the reporting person was awarded 13,570 restricted stock units (\"RSUs\") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs partially vest in three installments of 4,524 units, 4,523 units, and 4,523 units on each of June 1, 2024, July 1, 2024 and August 1, 2024, respectively, are also subject to further time-based vesting in a single installment on May 1, 2025, and are generally subject to continued service throughout each applicable vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested."}],"balance_after":118485,"source":{"system":"sec-edgar","filing":"0001477932-24-003483","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793224003483/form4.xml","form_type":"4"}},{"id":1670364,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":64382,"kind":"person","name":"Kway Jasmine","position":1,"cik":"0001808135","reported_name":"Kway Jasmine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO - Singapore Volition"}}],"security":"Common Stock","published_at":"2024-01-26T21:04:47.000Z","date":"2024-01-24","kind":"grant","planned":false,"acquired":true,"shares":28475,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On September 28, 2023, the reporting person was awarded 67,000 restricted stock units (\"RSUs\") under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to December 31, 2023 and June 30, 2024 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 28,475 RSUs vesting. The RSUs are further subject to a 3-year time-based vesting schedule, vesting in three installments of 9,492 units, 9,492 units, and 9,491 units on each of September 28, 2024, September 28, 2025 and September 28, 2026, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested."}],"balance_after":104915,"source":{"system":"sec-edgar","filing":"0001477932-24-000412","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793224000412/form4.xml","form_type":"4"}},{"id":1797270,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":64382,"kind":"person","name":"Kway Jasmine","position":1,"cik":"0001808135","reported_name":"Kway Jasmine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO - Singapore Volition"}}],"security":"Common Stock","published_at":"2023-08-25T15:49:45.000Z","date":"2023-08-24","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":1.2,"value":6000.0,"ownership":{"direct":false,"nature":"By Spouse"},"balance_after":10400,"source":{"system":"sec-edgar","filing":"0001477932-23-006470","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793223006470/form4.xml","form_type":"4"}},{"id":1833376,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":64382,"kind":"person","name":"Kway Jasmine","position":1,"cik":"0001808135","reported_name":"Kway Jasmine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO - Singapore Volition"}}],"security":"Common Stock","published_at":"2023-07-07T20:01:48.000Z","date":"2023-07-05","kind":"grant","planned":false,"acquired":true,"shares":22050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On October 4, 2022, the reporting person was awarded 49,000 restricted stock units (\"RSUs\") under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to December 31, 2022 and June 30, 2023 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 22,050 RSUs vesting. The RSUs are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 7,350 units on each of October 4, 2023, October 4, 2024 and October 4, 2025, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. As reported in October 2022 and January 2023 respectively, the rights with respect to 8,575 RSUs and 18,375 RSUs subject to the award previously vested and remain subject to time-based vesting."}],"balance_after":76440,"source":{"system":"sec-edgar","filing":"0001477932-23-005112","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793223005112/form4.xml","form_type":"4"}},{"id":2055278,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":64382,"kind":"person","name":"Kway Jasmine","position":1,"cik":"0001808135","reported_name":"Kway Jasmine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO - Singapore Volition"}}],"security":"Common Stock","published_at":"2023-01-13T21:02:39.000Z","date":"2023-01-12","kind":"grant","acquired":true,"shares":18375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On October 4, 2022, the reporting person was awarded 49,000 restricted stock units under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to December 31, 2022 and June 30, 2023 and also subject to time-based vesting.  Certain of the performance goals were met, resulting in the rights with respect to 18,375 restricted stock units vesting.  The restricted stock units are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 6,125 units on each of October 4, 2023, October 4, 2024 and October 4, 2025, respectively.  Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.  As reported in October 2022, the rights with respect to 8,575 restricted stock units subject to the award previously vested and remain subject to time-based vesting."}],"balance_after":54390,"source":{"system":"sec-edgar","filing":"0001477932-23-000269","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793223000269/form4.xml","form_type":"4"}},{"id":2137417,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":64382,"kind":"person","name":"Kway Jasmine","position":1,"cik":"0001808135","reported_name":"Kway Jasmine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO - Singapore Volition"}}],"security":"Common Stock","published_at":"2022-10-14T20:01:42.000Z","date":"2022-10-13","kind":"grant","acquired":true,"shares":8575,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On October 4, 2022, the reporting person was awarded 49,000 restricted stock units under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to December 31, 2022 and June 30, 2023 and also subject to time-based vesting.  Certain of the performance goals were met, resulting in the rights with respect to 8,575 restricted stock units vesting.  The restricted stock units are further subject to a 3-year time-based vesting schedule, vesting in three installments of 2,859 units, 2,858 units, and 2,858 units on each of October 4, 2023, October 4, 2024 and October 4, 2025, respectively.  Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested."}],"balance_after":36015,"source":{"system":"sec-edgar","filing":"0001477932-22-007692","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793222007692/form4.xml","form_type":"4"}},{"id":2222594,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":64382,"kind":"person","name":"Kway Jasmine","position":1,"cik":"0001808135","reported_name":"Kway Jasmine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO - Singapore Volition"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-24T20:03:03.000Z","date":"2022-06-23","kind":"grant","acquired":true,"shares":32869,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On August 3, 2021, the reporting person was granted an option to purchase 50,567 shares of common stock, subject to vesting upon achievement of certain corporate performance goals on or prior to July 1, 2022 and also subject to time-based vesting.  Certain of the performance goals were met, resulting in the rights with respect to 32,869 shares vesting.  The vested shares are further subject to a 2-year time based vesting schedule, vesting in two installments of 16,435 shares and 16,434 shares on each of August 3, 2022 and August 3, 2023, respectively.  As reported in April 2022, the rights with respect to the remaining 17,698 shares subject to the award previously vested and remain subject to time-based vesting."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On August 3, 2021, the reporting person was granted an option to purchase 50,567 shares of common stock, subject to vesting upon achievement of certain corporate performance goals on or prior to July 1, 2022 and also subject to time-based vesting.  Certain of the performance goals were met, resulting in the rights with respect to 32,869 shares vesting.  The vested shares are further subject to a 2-year time based vesting schedule, vesting in two installments of 16,435 shares and 16,434 shares on each of August 3, 2022 and August 3, 2023, respectively.  As reported in April 2022, the rights with respect to the remaining 17,698 shares subject to the award previously vested and remain subject to time-based vesting."}],"balance_after":50567,"derivative":{"exercise_price":3.4,"expiration_date":"2031-08-03","underlying":"Common Stock","underlying_shares":32869},"source":{"system":"sec-edgar","filing":"0001477932-22-004658","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793222004658/form4.xml","form_type":"4"}},{"id":2222593,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":64382,"kind":"person","name":"Kway Jasmine","position":1,"cik":"0001808135","reported_name":"Kway Jasmine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO - Singapore Volition"}}],"security":"Common Stock","published_at":"2022-06-24T20:03:03.000Z","date":"2022-06-23","kind":"grant","acquired":true,"shares":17836,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On August 3, 2021, the reporting person was awarded 27,440 restricted stock units, subject to vesting upon achievement of certain corporate performance goals on or prior to July 1, 2022 and also subject to time-based vesting.  Certain of the performance goals were met, resulting in the rights with respect to 17,836 restricted stock units vesting.  The restricted stock units are further subject to a 2-year time-based vesting schedule, vesting in two equal installments of 8,918 units on each of August 3, 2022 and August 3, 2023, respectively.  Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.  As reported in April 2022, the rights with respect to the remaining 9,604 restricted stock units subject to the award previously vested and remain subject to time-based vesting."}],"balance_after":27440,"source":{"system":"sec-edgar","filing":"0001477932-22-004658","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793222004658/form4.xml","form_type":"4"}},{"id":2300872,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":64382,"kind":"person","name":"Kway Jasmine","position":1,"cik":"0001808135","reported_name":"Kway Jasmine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO - Singapore Volition"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-08T20:01:10.000Z","date":"2022-04-07","kind":"grant","acquired":true,"shares":17698,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On August 3, 2021, the reporting person was granted an option to purchase 50,567 shares of common stock, subject to vesting upon achievement of certain corporate performance goals on or prior to July 1, 2022 and also subject to time-based vesting.  Certain of the performance goals were met, resulting in the rights with respect to 17,698 shares vesting.  The vested shares are further subject to a 2-year time based vesting schedule, vesting in two equal installments of 8,849 shares on each of August 3, 2022 and August 3, 2023, respectively."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On August 3, 2021, the reporting person was granted an option to purchase 50,567 shares of common stock, subject to vesting upon achievement of certain corporate performance goals on or prior to July 1, 2022 and also subject to time-based vesting.  Certain of the performance goals were met, resulting in the rights with respect to 17,698 shares vesting.  The vested shares are further subject to a 2-year time based vesting schedule, vesting in two equal installments of 8,849 shares on each of August 3, 2022 and August 3, 2023, respectively."}],"balance_after":17698,"derivative":{"exercise_price":3.4,"expiration_date":"2031-08-03","underlying":"Common Stock","underlying_shares":17698},"source":{"system":"sec-edgar","filing":"0001477932-22-002174","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793222002174/form4.xml","form_type":"4"}},{"id":2300871,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":64382,"kind":"person","name":"Kway Jasmine","position":1,"cik":"0001808135","reported_name":"Kway Jasmine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO - Singapore Volition"}}],"security":"Common Stock","published_at":"2022-04-08T20:01:10.000Z","date":"2022-04-07","kind":"grant","acquired":true,"shares":9604,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On August 3, 2021, the reporting person was awarded 27,440 restricted stock units, subject to vesting upon achievement of certain corporate performance goals on or prior to July 1, 2022 and also subject to time-based vesting.  Certain of the performance goals were met, resulting in the rights with respect to 9,604 restricted stock units vesting.  The restricted stock units are further subject to a 2-year time-based vesting schedule, vesting in two equal installments of 4,802 units on each of August 3, 2022 and August 3, 2023, respectively.  Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested."}],"balance_after":9604,"source":{"system":"sec-edgar","filing":"0001477932-22-002174","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793222002174/form4.xml","form_type":"4"}},{"id":2478311,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":64382,"kind":"person","name":"Kway Jasmine","position":1,"cik":"0001808135","reported_name":"Kway Jasmine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO - Singapore Volition"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-12-10T21:06:08.000Z","date":"2021-12-08","kind":"grant","acquired":true,"shares":55000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions involved an amendment of outstanding options, resulting in the deemed cancellation of the \"old\" options and the grant of \"replacement\" options.  The \"old\" options were originally granted on April 13, 2020, vested in full and were exercisable at 12 months from the date of grant, and were exercisable for five years from the date first exercisable.  The \"replacement\" options are fully-vested and expire on April 13, 2030 (ten years from the original date of grant)."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported transactions involved an amendment of outstanding options, resulting in the deemed cancellation of the \"old\" options and the grant of \"replacement\" options.  The \"old\" options were originally granted on April 13, 2020, vested in full and were exercisable at 12 months from the date of grant, and were exercisable for five years from the date first exercisable.  The \"replacement\" options are fully-vested and expire on April 13, 2030 (ten years from the original date of grant)."}],"balance_after":55000,"derivative":{"exercise_price":3.6,"exercise_date":"2021-04-13","expiration_date":"2030-04-13","underlying":"Common Stock","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0001477932-21-009123","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793221009123/form4.xml","form_type":"4"}},{"id":2478310,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":64382,"kind":"person","name":"Kway Jasmine","position":1,"cik":"0001808135","reported_name":"Kway Jasmine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO - Singapore Volition"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-12-10T21:06:08.000Z","date":"2021-12-08","kind":"disposition_to_issuer","acquired":false,"shares":55000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions involved an amendment of outstanding options, resulting in the deemed cancellation of the \"old\" options and the grant of \"replacement\" options.  The \"old\" options were originally granted on April 13, 2020, vested in full and were exercisable at 12 months from the date of grant, and were exercisable for five years from the date first exercisable.  The \"replacement\" options are fully-vested and expire on April 13, 2030 (ten years from the original date of grant)."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported transactions involved an amendment of outstanding options, resulting in the deemed cancellation of the \"old\" options and the grant of \"replacement\" options.  The \"old\" options were originally granted on April 13, 2020, vested in full and were exercisable at 12 months from the date of grant, and were exercisable for five years from the date first exercisable.  The \"replacement\" options are fully-vested and expire on April 13, 2030 (ten years from the original date of grant)."}],"balance_after":0,"derivative":{"exercise_price":3.6,"exercise_date":"2021-04-13","expiration_date":"2026-04-13","underlying":"Common Stock","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0001477932-21-009123","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793221009123/form4.xml","form_type":"4"}},{"id":2524055,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":64382,"kind":"person","name":"Kway Jasmine","position":1,"cik":"0001808135","reported_name":"Kway Jasmine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO - Singapore Volition"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-05T20:06:23.000Z","date":"2021-11-03","kind":"grant","acquired":true,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The reported transactions involved an amendment of outstanding options, resulting in the deemed cancellation of the \"old\" options and the grant of \"replacement\" options.  The \"old\" options were originally granted on January 23, 2018, vested in full and were exercisable at 12 months from the date of grant, and were exercisable for five years from the date first exercisable.  The \"replacement\" options are fully-vested and expire on January 23, 2028 (ten years from the original date of grant)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported transactions involved an amendment of outstanding options, resulting in the deemed cancellation of the \"old\" options and the grant of \"replacement\" options.  The \"old\" options were originally granted on January 23, 2018, vested in full and were exercisable at 12 months from the date of grant, and were exercisable for five years from the date first exercisable.  The \"replacement\" options are fully-vested and expire on January 23, 2028 (ten years from the original date of grant)."}],"balance_after":50000,"derivative":{"exercise_price":4,"exercise_date":"2019-01-23","expiration_date":"2028-01-23","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001477932-21-007868","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793221007868/form4.xml","form_type":"4"}},{"id":2524054,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":64382,"kind":"person","name":"Kway Jasmine","position":1,"cik":"0001808135","reported_name":"Kway Jasmine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO - Singapore Volition"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-05T20:06:23.000Z","date":"2021-11-03","kind":"disposition_to_issuer","acquired":false,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The reported transactions involved an amendment of outstanding options, resulting in the deemed cancellation of the \"old\" options and the grant of \"replacement\" options.  The \"old\" options were originally granted on January 23, 2018, vested in full and were exercisable at 12 months from the date of grant, and were exercisable for five years from the date first exercisable.  The \"replacement\" options are fully-vested and expire on January 23, 2028 (ten years from the original date of grant)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported transactions involved an amendment of outstanding options, resulting in the deemed cancellation of the \"old\" options and the grant of \"replacement\" options.  The \"old\" options were originally granted on January 23, 2018, vested in full and were exercisable at 12 months from the date of grant, and were exercisable for five years from the date first exercisable.  The \"replacement\" options are fully-vested and expire on January 23, 2028 (ten years from the original date of grant)."}],"balance_after":0,"derivative":{"exercise_price":4,"exercise_date":"2019-01-23","expiration_date":"2024-01-23","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001477932-21-007868","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793221007868/form4.xml","form_type":"4"}},{"id":2524053,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":64382,"kind":"person","name":"Kway Jasmine","position":1,"cik":"0001808135","reported_name":"Kway Jasmine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO - Singapore Volition"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-05T20:06:23.000Z","date":"2021-11-03","kind":"grant","acquired":true,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions involved an amendment of outstanding options, resulting in the deemed cancellation of the \"old\" options and the grant of \"replacement\" options.  The \"old\" options were originally granted on January 1, 2017, vested in full and were exercisable at 12 months from the date of grant, and were exercisable for five years from the date first exercisable.  The \"replacement\" options are fully-vested and expire on January 1, 2027 (ten years from the original date of grant)."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported transactions involved an amendment of outstanding options, resulting in the deemed cancellation of the \"old\" options and the grant of \"replacement\" options.  The \"old\" options were originally granted on January 1, 2017, vested in full and were exercisable at 12 months from the date of grant, and were exercisable for five years from the date first exercisable.  The \"replacement\" options are fully-vested and expire on January 1, 2027 (ten years from the original date of grant)."}],"balance_after":50000,"derivative":{"exercise_price":4.8,"exercise_date":"2018-01-01","expiration_date":"2027-01-01","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001477932-21-007868","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793221007868/form4.xml","form_type":"4"}},{"id":2524052,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":64382,"kind":"person","name":"Kway Jasmine","position":1,"cik":"0001808135","reported_name":"Kway Jasmine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO - Singapore Volition"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-05T20:06:23.000Z","date":"2021-11-03","kind":"disposition_to_issuer","acquired":false,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions involved an amendment of outstanding options, resulting in the deemed cancellation of the \"old\" options and the grant of \"replacement\" options.  The \"old\" options were originally granted on January 1, 2017, vested in full and were exercisable at 12 months from the date of grant, and were exercisable for five years from the date first exercisable.  The \"replacement\" options are fully-vested and expire on January 1, 2027 (ten years from the original date of grant)."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported transactions involved an amendment of outstanding options, resulting in the deemed cancellation of the \"old\" options and the grant of \"replacement\" options.  The \"old\" options were originally granted on January 1, 2017, vested in full and were exercisable at 12 months from the date of grant, and were exercisable for five years from the date first exercisable.  The \"replacement\" options are fully-vested and expire on January 1, 2027 (ten years from the original date of grant)."}],"balance_after":0,"derivative":{"exercise_price":4.8,"exercise_date":"2018-01-01","expiration_date":"2023-01-01","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001477932-21-007868","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000147793221007868/form4.xml","form_type":"4"}},{"id":3177009,"issuer":{"id":8241,"kind":"organization","name":"VOLITIONRX LTD"},"owners":[{"id":64382,"kind":"person","name":"Kway Jasmine","position":1,"cik":"0001808135","reported_name":"Kway Jasmine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO-Singapore Volition"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-04-15T21:12:50.000Z","date":"2020-04-13","kind":"grant","acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"A total of 55,000 Options were granted on April 13, 2020 under the Company's 2015 Stock Incentive Plan.  The Options vest in full twelve months from the date of grant."}],"balance_after":55000,"derivative":{"exercise_price":3.6,"exercise_date":"2021-04-13","expiration_date":"2026-04-13","underlying":"Common Stock","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0001078782-20-000266","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/93314/000107878220000266/primary_doc.xml","form_type":"4"}}]}